News|Articles|August 23, 2013

Skyepharma Names CFO and Executive Director

Andrew Derodra will join Skyepharma in the fourth quarter of 2013.

The drug-delivery company Skypharma has appointed Andrew Derodra as CFO and an executive director, effective in the fourth quarter of 2013.

Derodra joins Skyepharma from Tate & Lyle, where he had been group vice-president, finance and control, since 2011. He has spent 23 years working in senior finance roles for various companies, including SABMiller, Diageo, British Airways, and Reed Elsevier.

Source: Skypharma

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content